Almost one year ago, the Supreme Court decided Bristol-Myers Squibb v. Superior Court, a near unanimous decision placing important safeguards that protect the constitutional rights of defendants on where they can be sued. On June 4, ILR will convene a panel of experts to discuss the practical implications of the case and what it did (and did not do) to bring predictability to litigants defending suits across the country.

We’ll also discuss how the limits of BMS are being tested in the courts and how defendants can respond effectively in battleground areas such as:

• Class Actions and Unnamed Class Members
• Applicability to Federal Courts
• Jurisdictional Discovery
• Consent Jurisdiction and Waiver

During the event, ILR will release research addressing the paradigm-shifting consequences of the Supreme Court’s decision in Bristol-Myers Squibb, which reined in forum shopping and reinforced the viability of personal jurisdiction as a defense. This research encourages corporations to be vigilant in litigating personal jurisdiction issues in lower courts in order to ensure this paradigm shift does not take root, and provides practical examples and guidance for doing so.

Reserve your seat today!